- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
EyeGene Inc (185490)
Track today's live EyeGene (185490) share price, performance and key data on this page with our current KOSDAQ:185490 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the EyeGene share price on the KOSDAQ exchange. Use the dropdown to switch exchange for the 185490 share price, head to our technical summary section, which provides analysis on EyeGene share price buy/sell indicators using real-time data (or discuss the EyeGene (185490) stock price today with other investors in the EyeGene KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ:185490 share price (ISIN: KR7185490000) to enhance your trading decisions with our free investment tools and resources.
What Is the EyeGene Inc Share Price Today?
The EyeGene share price today is 1,651.
What Is the Stock Symbol for EyeGene Inc
The stock symbol (or 'ticker') for EyeGene Inc is "185490."
What Stock Exchange Does EyeGene Inc Trade On?
EyeGene Inc is listed and trades on the KOSDAQ stock exchange.
Is EyeGene Inc a Good Stock to Buy?
Determining whether EyeGene (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current KQ:185490 share price (ISIN: KR7185490000) to enhance your trading decisions with our free investment tools and resources.
What Is the EyeGene Inc Share Price Today?
The EyeGene share price today is 1,651.
What Is the Stock Symbol for EyeGene Inc
The stock symbol (or 'ticker') for EyeGene Inc is "185490."
What Stock Exchange Does EyeGene Inc Trade On?
EyeGene Inc is listed and trades on the KOSDAQ stock exchange.
Is EyeGene Inc a Good Stock to Buy?
Determining whether EyeGene (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
KOSDAQ
Currency in KRW
1,651
+25(+1.54%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,606
1,672
52 wk Range
1,182
3,450
185490 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,6061,672
52 wk Range
1,1823,450
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
185490 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Earnings
Latest Release
15/05/2026
EPS / Forecast
-79.85 / --
Revenue / Forecast
1.27B / --
Compare 185490 to Peers and Sector
Metrics to compare | 185490 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship185490PeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.3x | −10.8x | −0.4x | |
PEG Ratio | 0.31 | −0.28 | 0.00 | |
Price/Book | 1.3x | 1.7x | 2.6x | |
Price / LTM Sales | 17.5x | 5.8x | 3.0x | |
Upside (Analyst Target) | - | 129.0% | 50.7% | |
Fair Value Upside | Unlock | 20.5% | 7.2% | Unlock |
EyeGene Inc. engages in the research and development of biopharmaceutical drugs for the treatment and prevention of age-related diseases in South Korea. Its product pipeline comprises EG-Mirotin, which has completed Phase 2a clinical trial to treat diabetic retinopathy; EG-Decorin which completed Phase 2 clinical trial for the treatment of pressure ulcers and wound healing; and EG-Myocin, which has completed Phase II clinical trials for the treatment of myocardial ischemia/reperfusion injury. It also develops EG-HZ, which has completed phase 1 clinical trial for the treatment of herpes zoster; EG-HPV which completed Phase 1 clinical trial to treat cervical cancer; EG-COVID that is in phase I clinical trial for the treatment of covid; and EG-TB for the tuberculosis vaccine and is in preclinical trial. In addition, the company offers vitalDB for beautiful vitality. EyeGene Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the EyeGene (KOSDAQ: 185490) Share Price Today?
The EyeGene stock price today is 1,651 KRW.
What Stock Exchange Does EyeGene (185490) Trade On?
EyeGene is listed and trades on the KOSDAQ.
What Is the Ticker (Stock Symbol) for EyeGene?
The stock symbol (also called a 'ticker') for EyeGene is "185490."
What Is the Current EyeGene Market Capitalisation?
As of today, EyeGene (KOSDAQ: 185490) market cap is 70.29B KRW.
What Is EyeGene's (185490) Earnings Per Share (TTM)?
The EyeGene EPS is currently -506 (Trailing Twelve Months).
Is 185490 a Buy or Sell From a Technical Analyst Perspective?
Based on today's EyeGene moving averages and other technical indicators, the daily buy/sell signal for 185490 stock is Strong Buy.
How Many Times Has EyeGene Stock Split?
EyeGene has split 2 times. (See the 185490 stock split history page for full effective split date and price information.)
What is the current trading status of EyeGene (KOSDAQ: 185490)?
As of 07/08/2026, EyeGene (185490) is trading at a share price of 1,651 KRW, with a previous close of 1,626 KRW. The stock has fluctuated within a day range of 1,606 KRW to 1,672 KRW, while its 52-week range spans from 1,182 KRW to 3,450 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.